Cognizant, a global leader in technology and professional services, today announced a major expansion of its India operations with plans to develop a state-of-the-art campus here in Andhra Pradesh.

In the first five months of 2025, 305 samples of a wide range of drugs – including lifesaving medication – drawn from ...

Pharma major, Alembic Pharma on Thursday said that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility ...

In its filing with the bourses, Zydus informed that these observations received were minor, and not related to data integrity ...

The follow-up audit, conducted under Good Manufacturing Practices (GMP), took place from June 9 to June 18, 2025, at the company's facility in SEZ 1 near Matoda, Ahmedabad.

Alembic Pharma has received a cumulative total of 223 Abbreviated New Drug Application (ANDA) approvals (200 final approvals ...

The forecast is based on current observations, particularly the formation of a low-pressure area near the Konkan region of Ratnagiri district.

One of India's largest drugmaker shares slipped on Monday, June 16, after the US Food and Drug Administration (US FDA) issued ...

CHENNAI: Shares of Sun Pharmaceutical Industries Ltd. are under investor scrutiny today following two significant ...

Sun Pharma said the US FDA issued a Form-483 with eight observations after inspecting its Halol facility from June 2–13.